コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 VDR 4-1 also effectively suppressed secondary hyperparat
2 VDR activation exerts anti-inflammatory effects in immun
3 VDR and RXR expression were assessed by immunohistochemi
4 VDR associated with PU.1 in Th9 cells.
5 VDR expression could potentially be used as a biomarker
6 VDR expression is induced in hepatic macrophages by ER s
7 VDR expression was independently protective for melanoma
8 VDR modifies gene expression by binding DNA as a heterod
9 VDR polymorphisms (Taq-I, Bsm-I, Apa-I and Fok-I) were i
10 VDR signaling in macrophages regulates a shift between p
11 VDR(-/-) and VDD diabetic mice (diabetic for 8 and 20 we
12 VDR(-/-) and VDD diabetic mice also showed significantly
13 VDR(DeltaPC) mice also showed high susceptibility to sma
14 VDR(DeltaPC) mice had significantly higher inflammation
15 VDR-BVs are enriched in consensus RXR::VDR binding motif
16 VDR-null (VDR(-/-)) mice exhibit lack of postmorphogenic
17 VDR-occupied sites were present in both the kidney and N
18 nificantly varied according to genotype at 2 VDR SNPs (rs7968585 and rs731236) in linkage disequilibr
20 (95% CI): VDR >/= median = 0.67 (0.48-0.93); VDR < median = 0.98 (0.72-1.35), P heterogeneity = 0.12]
21 rated potent transcriptional activities in a VDR reporter gene assay, and significantly ameliorated c
23 B2-dependent gene upregulation, suggesting a VDR-independent anti-inflammatory effect of paricalcitol
25 ssociated with altered VDR binding affinity (VDR-BVs) using a high-resolution (ChIP-exo) genome-wide
27 citriol), a naturally occurring VDR agonist, VDR 4-1 therapy even at high doses did not induce hyperc
28 riants significantly associated with altered VDR binding affinity (VDR-BVs) using a high-resolution (
30 Combining carriers of A allele in CYP2R1 and VDR genes with IL28B C/C genotype increased the probabil
31 scue experiments, we confirmed vitamin D and VDR inhibited LPS- or activated CD4(+) T cell-induced mi
35 of 25-hydroxylase, 1-alpha-hydroxylase, and VDR, and hypomethylation of CYP24A1 was observed in HFD-
38 ced in hepatic macrophages by ER stress, and VDR plays a dual regulatory role in macrophages by prote
40 4A1 and CYP27B1 protein expression in WT and VDR KO cells, and stimulated cell proliferation in both
45 nteric lymph node cultures from VDR KO and B-VDR KO mice secreted higher IgE ex vivo than wild-type (
46 VDR KO mice was 2-fold greater than in the B-VDR KO mice, suggesting that VDR deficiency in non-B cel
47 cific VDR (T-VDR) KO, B cell-specific VDR (B-VDR) KO, and vitamin D deficient mice were used to deter
48 d to determine degree of association between VDR polymorphisms and periodontal status adjusted for kn
49 /-) mice, and an inverse correlation between VDR and miR-802 was found in human biopsy specimens of O
51 eptor (VDR), enabling an interaction between VDR and the coactivator, SRC-3 (NCOA3), thereby increasi
55 o vitamin D supplementation is influenced by VDR polymorphisms, specifically for carriers of Taq-I GG
56 ential gut-liver-microbiome axis mediated by VDR that might trigger downstream metabolic disorders.
57 Moreover, this association was modified by VDR rs7975232 (interaction P = 0.0072), where increased
58 um ASBT and decreased liver IL-10, FXR, CAR, VDR, BSEP, MRP2, MRP3, MRP4 was also observed in ANIT-in
60 VDR [>/=30 ng/mL vs. <30 ng/mL RR (95% CI): VDR >/= median = 0.67 (0.48-0.93); VDR < median = 0.98 (
64 e of a causal relationship between vitamin D-VDR signaling and melanoma survival, which should be exp
65 riptomes to understand the role of vitamin D-VDR signaling and replicated the findings in The Cancer
67 ation studies showed that elevated vitamin D-VDR signaling inhibited Wnt/beta-catenin signaling genes
68 ship between the oncogene Ras, the vitamin D/VDR axis and the expression of DNA repair factors, in th
69 DR) during OIS, and a role for the vitamin D/VDR axis regulating the levels of these DNA repair facto
72 ollectively, our data suggest that vitamin D/VDR signaling suppresses oral keratinocyte apoptosis by
77 cantly increased after intestinal epithelial VDR deletion and were further increased by the high-fat
80 -skeletal example of a tissue that expresses VDR that not only makes vitamin D but also can metaboliz
82 he IHC examination of human CCA specimen for VDR revealed that higher VDR expression was linked with
84 sion was enhanced in oral keratinocytes from VDR(-/-) mice, and an inverse correlation between VDR an
85 endotoxin levels were high in the serum from VDR(DeltaIEC) mice and made mice susceptible to colitis.
88 ter activity, regulate VDR downstream genes (VDR, CYP24A1, TRPV6 and CYP27B1), and inhibit the produc
89 ts in 7 vitamin D and calcium pathway genes (VDR, GC, DHCR7, CYP2R1, CYP27B1, CYP24A1, and CASR) modi
92 presentation of transcription factors HIF1A, VDR, and CLOCK, among others, and of GO term pathways re
102 quence variant (c.2 T > C; p.1Met?) found in VDR is an initiation coding change and was detected in c
104 ficiency normalized PPARgamma mRNA levels in VDR(-/-) keratinocytes and restored anagen responsivenes
107 entially expressed genes are up-regulated in VDR(-/-) KSCs; thus, the VDR is a transcriptional suppre
112 (-/-) mice, vitamin D(3) treatment increased VDR and ATG16L1 protein expression levels, which activat
116 the effects of vitamin D receptor knockout (VDR(-/-)) and vitamin D deficiency (VDD) on corneal epit
117 generated Paneth cell-specific VDR knockout (VDR(DeltaPC)) mice to investigate the molecular mechanis
118 tment of co-regulatory complexes by liganded VDR leads to changes in gene expression that result in d
122 ic inflammation conditions of the DIO model, VDR activation by the vitamin D analog calcipotriol redu
127 mors with high expression of stromal nuclear VDR [>/=30 ng/mL vs. <30 ng/mL RR (95% CI): VDR >/= medi
129 ,25-D3 or calcitriol), a naturally occurring VDR agonist, VDR 4-1 therapy even at high doses did not
133 dicates that the transcriptional activity of VDR is diminished under inflammatory conditions, which m
134 uence tailor the transcriptional activity of VDR toward specific target genes.The vitamin D receptor/
137 s from mice with tissue-specific deletion of VDR in intestinal epithelial cells or myeloid cells.
139 ons correlate with the mucosal expression of VDR as well as epithelial junction proteins and inversel
142 nsights into the tissue-specific function of VDR in modulating the balance between autophagy and apop
143 Thus, the immunomodulatory functions of VDR in macrophages are critical in hepatic ER stress res
148 ing muscle atrophy, we studied the impact of VDR knockdown (KD) on mature skeletal muscle in vivo, an
149 ceptor (VDR) only in the distal intestine of VDR null mice (KO/TG mice) results in the normalization
154 ct of diet was more prominent due to loss of VDR as indicated by the differences in metabolites gener
156 r published, that would describe presence of VDR, hydroxylases CYP27B1 and CYP24A1, and RORalpha and
161 sights into the tissue-specific functions of VDRs in maintaining Paneth cell alertness to pathogens i
165 In addition, transgenic mice overexpressing VDR in beta-cells were protected against streptozotocin-
169 and fibrosis through its ability to promote VDR signaling in HSCs, whose activation supports HCC.
170 hown to act through multiple receptors (PXR, VDR, TGR5 and S1PR2), as well as to have receptor-indepe
172 ets were associated with vitamin D receptor (VDR) (rs2228570, P = 0.002, q = 0.04) and MMP3 (rs520540
174 Here we demonstrate that vitamin D receptor (VDR) activation mitigates hepatic ER stress response, wh
175 re, we document that the vitamin D receptor (VDR) acts as a master transcriptional regulator of autop
176 east tumor expression of vitamin D receptor (VDR) and retinoid X receptor-alpha (RXR) has not been in
178 Furthermore, we found vitamin D receptor (VDR) binding sites in the promoters of miR-27a/b genes a
180 marked downregulation of vitamin D receptor (VDR) during OIS, and a role for the vitamin D/VDR axis r
181 Recently, we found that vitamin D receptor (VDR) enhanced Claudin-2 expression in colon and that bil
183 Polymorphisms of the vitamin D receptor (VDR) gene have been implicated in susceptibility to infe
184 , an association between vitamin D receptor (VDR) gene polymorphisms and diabetes has also been descr
185 in the gene encoding the vitamin D receptor (VDR) have been widely reported to associate with suscept
190 sgenic expression of the vitamin D receptor (VDR) only in the distal intestine of VDR null mice (KO/T
191 e-specific modulation of vitamin D receptor (VDR) signaling had organ-restricted effects, with cardia
192 sive effect of vitamin D/vitamin D receptor (VDR) signaling has been shown in the context of oral lic
193 wed by discussion of the vitamin D receptor (VDR) that mediates the cellular actions of 1,25(OH)(2)D.
195 -alpha-hydroxylase), and vitamin D receptor (VDR) were downregulated in the livers of mice fed an HFD
196 (CYP2R1)(rs10741657AG), vitamin D receptor (VDR)(rs2228570AG, rs1544410CT), oligoadenylate synthetas
199 erphosphorylation of the vitamin D receptor (VDR), enabling an interaction between VDR and the coacti
200 its actions through the vitamin D receptor (VDR), the expression of which was recently confirmed in
201 ranscription factor, the vitamin D receptor (VDR), whose activating ligand vitamin D has been propose
202 H)2D3 interacts with the vitamin D receptor (VDR), with similar potency to its native ligand, 1alpha,
212 liganded heterodimers of vitamin D receptor (VDR)/RXR-alpha and retinoic acid receptor-gamma (RAR-gam
213 egulation by the vitamin D nuclear receptor (VDR) could provide an alternative route for brain folate
216 ession in colon and that bile salt receptors VDR and Takeda G-protein coupled receptor5 (TGR5) were h
217 is of the expression of vitamin D receptors (VDR), the activating and inactivating hydroxylases, resp
218 ss the highest level of vitamin D receptors (VDRs) among nonparenchymal cells, whereas VDR expression
220 , stimulate VDRE-reporter activity, regulate VDR downstream genes (VDR, CYP24A1, TRPV6 and CYP27B1),
221 Genetically and environmentally regulated VDRs in the Paneth cells may set the threshold for the d
224 In this stringent test, these replicated VDR-BVs were significantly (q < 0.1) and substantially (
225 ur findings are consistent with altered RXR::VDR binding contributing to immunity-related diseases.
226 e approach's validity is underscored by RXR::VDR motif sequence being predictive of binding strength
228 this adverse effect is to develop selective VDR modulators (VDRMs) that differentially activate BGLA
230 ted with early AMD, 4 SNPs (RXRA) and 1 SNP (VDR) were associated with nvAMD, and 1 SNP (RXRA), 2 SNP
231 ciated with nvAMD, and 1 SNP (RXRA), 2 SNPs (VDR), and 1 SNP (CYP2R1) were associated with late AMD.
233 ell-specific VDR (T-VDR) KO, B cell-specific VDR (B-VDR) KO, and vitamin D deficient mice were used t
237 al transfection was used to induce sustained VDR-KD in C2C12 cells to analyse myogenic regulation.
238 gether, these results suggest that sustained VDR levels in beta-cells may preserve beta-cell mass and
240 Whole-body VDR KO, T cell-specific VDR (T-VDR) KO, B cell-specific VDR (B-VDR) KO, and vitamin D d
243 lic effects of calcipotriol, confirming that VDR activation in liver macrophages is required for the
247 erinsulinemic euglycemic clamp revealed that VDR activation greatly increased the glucose infusion ra
248 r than in the B-VDR KO mice, suggesting that VDR deficiency in non-B cells contributes to hyper-IgE i
249 sal and pathogenic microbiota, the role that VDRs in Paneth cells play in these responses is unknown.
252 indings point to a role of vitamin D and the VDR in modulating autophagy and cell death in both the n
253 es of mutations, we were able to dissect the VDR domain involved in the regulation of the Il9 gene.
254 vivo electrotransfer (IVE) to knock down the VDR in hind-limb tibialis anterior (TA) muscle for 10 da
257 To examine whether the polymorphisms in the VDR gene are associated with the development of NMSC and
259 ingle-nucleotide polymorphisms (SNPs) in the VDR, resulting in contradictory findings as to whether t
263 g of VDR(DeltaPC) and VDR(lox) mice made the VDR(DeltaPC) less vulnerable to dextran sulfate sodium c
266 ndicate a fundamental regulatory role of the VDR in the regulation of myogenesis and muscle mass, whe
267 dertaken to define the influence loss of the VDR on muscle fibre composition, protein synthesis, anab
268 ts ability to stimulate translocation of the VDR to the nucleus, stimulate VDRE-reporter activity, re
272 min D receptor (VDR) antagonists prevent the VDR activation function helix 12 from folding into its a
277 he 20S-OH moiety and the 25-OH moiety to the VDR, which may explain some differences in their biologi
278 that pretreatment of Folr1 KO mice with the VDR activating ligand, calcitriol (1,25-dihydroxyvitamin
280 ow that VitD is anti-lymphangiogenic through VDR-dependent anti-proliferative and pro-apoptotic mecha
284 In conclusion, we have identified a unique VDR agonist compound with beneficial effects in mouse mo
285 ensitivity, an effect that is dependent upon VDR within the paraventricular nucleus of the hypothalam
291 itigates hepatic ER stress response, whereas VDR knockout mice undergo persistent UPR activation and
294 ctions with the A-pocket in conjunction with VDR translocation studies suggest they may act on this n
297 s its nuclear localization, interaction with VDR, intra-nuclear trafficking, and binding to chromatin
299 nst background sets of variants lying within VDR-binding regions that had been matched in allele freq
300 eport the crystal structure of the zebrafish VDR ligand-binding domain in complex with the ZK168281 a